Benitec Biopharma
(NASDAQ) BNTC
Benitec Biopharma Financials at a Glance
Market Cap
$375.15M
Revenue (TTM)
$556.00K
Net Income (TTM)
$46.30M
EPS (TTM)
$-0.93
P/E Ratio
-11.75
Dividend
$0.00
Beta (Volatility)
0.84 (Low)
Dividend
$0.00
Beta (Volatility)
0.84 (Low)
Price
$10.93
Volume
1,897
Open
$10.63
Price
$10.93
Volume
1,897
Open
$10.63
Previous Close
$10.93
Daily Range
$10.63 - $10.99
52-Week Range
$9.85 - $17.15
Dividend
$0.00
Beta (Volatility)
0.84 (Low)
Price
$10.93
Volume
1,897
Open
$10.63
Previous Close
$10.93
Daily Range
$10.63 - $10.99
52-Week Range
$9.85 - $17.15
BNTC News
BNTC: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Benitec Biopharma
Industry
Biotechnology
Sector
Health CareEmployees
19
CEO
Jerel A. Banks, MD, PhD
Website
www.benitec.comHeadquarters
Hayward, CA 94545, US
BNTC Financials
Key Financial Metrics (TTM)
Gross Margin
-12%
Operating Margin
-91%
Net Income Margin
-83%
Return on Equity
-30%
Return on Capital
-27%
Return on Assets
-24%
Earnings Yield
-8.51%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$375.15M
Shares Outstanding
34.35M
Volume
1.90K
Short Interest
0.00%
Avg. Volume
160.91K
Financials (TTM)
Gross Profit
$396.00K
Operating Income
$41.77M
EBITDA
$41.70M
Operating Cash Flow
$23.59M
Capital Expenditure
$18.00K
Free Cash Flow
$23.61M
Cash & ST Invst.
$97.74M
Total Debt
$849.00K
Benitec Biopharma Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$120.00K
-48.1%
Gross Margin
0.00%
N/A
Market Cap
$375.15M
N/A
Market Cap/Employee
$23.45M
N/A
Employees
16
N/A
Net Income
$11.84M
-60.9%
EBITDA
$13.38M
-83.9%
Quarterly Fundamentals
Net Cash
$187.80M
+140.3%
Accounts Receivable
$130.00K
+6400.0%
Inventory
$0.00
N/A
Long Term Debt
$519.00K
N/A
Short Term Debt
$468.00K
+241.6%
Return on Assets
-24.28%
N/A
Return on Invested Capital
-26.90%
N/A
Free Cash Flow
$3.79M
+50.9%
Operating Cash Flow
$3.78M
+51.0%